Showing results (1-10 of 4,819) with videos related to
Sort By:
Pageof 482
Trends in Immunology|February 1, 2024
SARS-CoV-2 evolution from the BA.2.86 to JN.1 variants: unexpected consequencesXinling Wang, Lu Lu, Shibo JiangInternational Journal of Molecular Sciences|June 3, 2020
Broad-Spectrum Coronavirus Fusion Inhibitors to Combat COVID-19 and Other Emerging Coronavirus DiseasesXinling Wang, Shuai Xia, Qian Wang, et al.Molecules (Basel, Switzerland)|April 3, 2021
Synergistic Effect by Combining a gp120-Binding Protein and a gp41-Binding Antibody to Inactivate HIV-1 Virions and Inhibit HIV-1 InfectionXinling Wang, Miao Cao, Yanling Wu, et al.European Journal of Medicinal Chemistry|April 8, 2022
Design of artificial α-helical peptides targeting both gp41 deep pocket and subpocket as potent HIV-1 fusion inhibitorsHuan Wang, Xinling Wang, Jiahui Li, et al.ACS Infectious Diseases|April 3, 2020
Sodium Copper Chlorophyllin Is Highly Effective against Enterovirus (EV) A71 Infection by Blocking Its Entry into the Host CellZezhong Liu, Shuai Xia, Xinling Wang, et al.Journal of Medicinal Chemistry|July 15, 2021
A "Two-Birds-One-Stone" Approach toward the Design of Bifunctional Human Immunodeficiency Virus Type 1 Entry Inhibitors Targeting the CCR5 Coreceptor and gp41 N-Terminal Heptad Repeat RegionChao Wang, Xinling Wang, Huan Wang, et al.Emerging Microbes & Infections|August 3, 2023
An engineered recombinant protein containing three structural domains in SARS-CoV-2 S2 protein has potential to act as a pan-human coronavirus entry inhibitor or vaccine antigenXinling Wang, Lujia Sun, Zezhong Liu, et al.Cell & Bioscience|March 21, 2013
Controlling HIV sexual transmission: a major challenge for China's new leadershipShibo Jiang, Weihua Li, Lu LuMbio|January 18, 2022
A Toxin-Conjugated Recombinant Protein Targeting gp120 and gp41 for Inactivating HIV-1 Virions and Killing Latency-Reversing Agent-Reactivated Latent CellsXinling Wang, Wei Xu, Zezhong Liu, et al.Cellular & Molecular Immunology|July 12, 2020
Retraction Note to: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusionXinling Wang, Wei Xu, Gaowei Hu, et al.Pageof 482